Literature DB >> 31573630

Metformin for Type 2 Diabetes.

Alfredo Caturano1, Raffaele Galiero1, Pia Clara Pafundi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31573630     DOI： 10.1001/jama.2019.11489

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

1.  Tumor Necrosis Factor Receptor Superfamily Member 21 Induces Endothelial-Mesenchymal Transition in Coronary Artery Endothelium of Type 2 Diabetes Mellitus.

Authors:  Po-Chao Hsu; Jiun-Chi Huang; Wei-Chung Tsai; Wei-Wen Hung; Wei-An Chang; Ling-Yu Wu; Chao-Yuan Chang; Yi-Chun Tsai; Ya-Ling Hsu
Journal:  Biomedicines       Date:  2022-05-30

2.  Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia.

Authors:  Ashenafi Kibret Sendekie; Achamyeleh Birhanu Teshale; Yonas Getaye Tefera
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

Review 3.  Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?

Authors:  Teresa Salvatore; Pia Clara Pafundi; Raffaele Galiero; Luca Rinaldi; Alfredo Caturano; Erica Vetrano; Concetta Aprea; Gaetana Albanese; Anna Di Martino; Carmen Ricozzi; Simona Imbriani; Ferdinando Carlo Sasso
Journal:  Biomedicines       Date:  2020-12-22

4.  Trends in all-cause mortality and major causes of death between 2007 and 2018 among patients with diabetes in Taiwan.

Authors:  Jun-Sing Wang; Yi-Ling Wu; Horng-Yih Ou; Yi-Sun Yang; Chih-Cheng Hsu; Chii-Min Hwu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-09       Impact factor: 6.055

Review 5.  Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy.

Authors:  David S H Bell
Journal:  J Diabetes Res       Date:  2022-08-04       Impact factor: 4.061

6.  Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus.

Authors:  Chen Long; Yaling Tang; Jiangsheng Huang; Suo Liu; Zhenhua Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055

7.  A new predictive model for the concurrent risk of diabetic retinopathy in type 2 diabetes patients and the effect of metformin on amino acids.

Authors:  Zicheng Song; Weiming Luo; Bing Huang; Yunfeng Cao; Rongzhen Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

8.  Risk Factors for Progression of CKD with and without Diabetes.

Authors:  Xiaohong Zhang; Yuan Fang; Zhenhuan Zou; Pianpian Hong; Yongjie Zhuo; Yanfang Xu; Jianxin Wan
Journal:  J Diabetes Res       Date:  2022-08-22       Impact factor: 4.061

Review 9.  Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects.

Authors:  Giuseppe Palmiero; Arturo Cesaro; Erica Vetrano; Pia Clara Pafundi; Raffaele Galiero; Alfredo Caturano; Elisabetta Moscarella; Felice Gragnano; Teresa Salvatore; Luca Rinaldi; Paolo Calabrò; Ferdinando Carlo Sasso
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

10.  Greater Glycemic Burden Is Associated with Further Poorer Glycemic Control in Newly-Diagnosed Type 2 Diabetes Mellitus Patients.

Authors:  Wei-Lun Wen; Hui-Chun Huang; Hsiu-Chu Lin; Wan-Ching Lo; Szu-Chia Chen; Mei-Yueh Lee
Journal:  Nutrients       Date:  2022-01-13       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.